You are using an older browser version. Please use a supported version for the best MSN experience.

J&J kicks off final study of single-shot COVID-19 vaccine in 60,000 volunteers

The drug giant said it would begin a stage three trial of a single-shot vaccine, which could prove easier to administer than rivals that require two inoculations. This report produced by Zachary Goelman.
image beaconimage beaconimage beacon